In conclusion, this study provides the first evidence that ceAF can mitigate ulcerative colitis (UC) and TNF-α-induced inflammatory responses by inhibiting the LCK/ZAP70/LAT signaling pathway, thereby reducing TCR signaling hyperactivation. The gene discussed is LAT; the disease is ulcerative colitis.